Gaush Meditech (HKSE:02407) Long-Term Debt : HK$104.2 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Gaush Meditech Long-Term Debt?

Gaush Meditech's Long-Term Debt for the quarter that ended in Dec. 2023 was HK$104.2 Mil.

Gaush Meditech's quarterly Long-Term Debt declined from Dec. 2022 (HK$636.2 Mil) to Jun. 2023 (HK$182.8 Mil) and declined from Jun. 2023 (HK$182.8 Mil) to Dec. 2023 (HK$104.2 Mil).

Gaush Meditech's annual Long-Term Debt declined from Dec. 2021 (HK$972.8 Mil) to Dec. 2022 (HK$636.2 Mil) and declined from Dec. 2022 (HK$636.2 Mil) to Dec. 2023 (HK$104.2 Mil).

Gaush Meditech Long-Term Debt Historical Data

The historical data trend for Gaush Meditech's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gaush Meditech Long-Term Debt Chart

Gaush Meditech Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

231.05

972.76

636.20

104.23

Gaush Meditech Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Debt	Get a 7-Day Free Trial			972.76	857.70	636.20	182.82	104.23

Gaush Meditech (HKSE:02407) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Gaush Meditech Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Gaush Meditech's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Gaush Meditech (HKSE:02407) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gaush Meditech Ltd (HKSE:02407) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

F7Y:Germany

Address

No.11 Dongzhimen South Avenue, Room 1901, Building A, Zhonghui Plaza, Dongcheng District, Beijing, CHN

Website

https://www.gaush.com

Gaush Meditech Ltd is a provider of a broad spectrum of ophthalmic medical devices. The segments of the company include 1) Proprietary products segment develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; 2) Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; 3) Technical services segment provides warranty services, maintenance services and after-sales services related consumables; and 4) Others segment.

Executives

Orbimed Advisors Iii Limited	2102 Investment manager
Orbimed Asia Gp Iii, L.p.	2102 Investment manager
Orbimed Asia Partners Iii, L.p.	2102 Investment manager
Gao Tieta	2201 Interest of corporation controlled by you
Gaush Holding Ltd	2101 Beneficial owner
Cuprite Gem Investments Ltd	2101 Beneficial owner
Warburg Pincus (bermuda) Private Equity Gp Ltd.	2201 Interest of corporation controlled by you
Warburg Pincus (cayman) China-southeast Asia Ii Gp Llc	2201 Interest of corporation controlled by you
Warburg Pincus (cayman) China-southeast Asia Ii Gp, L.p.	2201 Interest of corporation controlled by you
Warburg Pincus China-southeast Asia Ii (cayman), L.p.	2201 Interest of corporation controlled by you
Warburg Pincus Partners Ii (cayman), L.p.	2201 Interest of corporation controlled by you

Gaush Meditech (HKSE:02407) Headlines

No Headlines